BioMed Research International

Inflammatory Joint Diseases


Status
Published

Lead Editor
Guest Editors

1The First Hospital of Xiamen University, Xiamen, China

2State University of New York at Buffalo School of Medicine, Buffalo, USA


Inflammatory Joint Diseases

Description

Arthritis is a common clinical feature in rheumatic diseases, including rheumatoid arthritis, spondylarthritis, crystal-induced arthritis, systemic lupus erythematosus, and Sjogren’s syndrome. Joint inflammation and damage may result in disability and morbidity. Understanding the pathogenesis of inflammatory joint diseases remains a complex problem, although the level of understanding has progressed considerably in recent years. Knowledge of the pathogenesis, diagnosis, and treatment of inflammatory joint arthritis will lead to significant clinical benefit. Immune dysregulation has been implicated in the development of arthritis. In this special issue, we invite researchers to contribute with original articles as well as review articles that will stimulate the continuing efforts to understand the underlying immune mechanism that drives the pathology of joint inflammatory diseases and that may disclose innovative treatment interventions. We are particularly interested in articles describing the novel mechanism; new treatment strategies; clinical studies; and advances in molecular genetics and molecular diagnostics.

Potential topics include, but are not limited to:

  • Recent development in understanding the pathogenesis of inflammatory joint diseases
  • New therapeutic strategies in inflammatory joint diseases
  • New diagnosis biomarkers and autoantibodies in inflammatory joint diseases
  • Clinical studies focused on the treatment of inflammatory joint diseases

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 973510
  • - Editorial

Inflammatory Joint Diseases

Guixiu Shi | Julian L. Ambrus | ... | Long Shen
  • Special Issue
  • - Volume 2015
  • - Article ID 765490
  • - Research Article

Designation of a Novel DKK1 Multiepitope DNA Vaccine and Inhibition of Bone Loss in Collagen-Induced Arthritic Mice

Xiaoqing Zhang | Sibo Liu | ... | Wenming Zhao
  • Special Issue
  • - Volume 2015
  • - Article ID 240210
  • - Research Article

Pim-2/mTORC1 Pathway Shapes Inflammatory Capacity in Rheumatoid Arthritis Synovial Cells Exposed to Lipid Peroxidations

Geng Yin | Yan Li | ... | Qi-bing Xie
  • Special Issue
  • - Volume 2015
  • - Article ID 913804
  • - Research Article

Association between Serum 25-Hydroxyvitamin D Level and Rheumatoid Arthritis

Xiaomin Cen | Yuan Liu | ... | Qibing Xie
  • Special Issue
  • - Volume 2015
  • - Article ID 150658
  • - Review Article

Medication Adherence in Patients with Rheumatoid Arthritis: The Effect of Patient Education, Health Literacy, and Musculoskeletal Ultrasound

Samantha Joplin | Rick van der Zwan | ... | Peter K. K. Wong
  • Special Issue
  • - Volume 2015
  • - Article ID 604872
  • - Research Article

Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNF α Blockers in Rheumatoid Arthritis and Spondyloarthritis Patients

Inesa Arstikyte | Giedre Kapleryte | ... | Algirdas Venalis
  • Special Issue
  • - Volume 2015
  • - Article ID 472174
  • - Research Article

Isotypes of Epstein-Barr Virus Antibodies in Rheumatoid Arthritis: Association with Rheumatoid Factors and Citrulline-Dependent Antibodies

Marie Wulff Westergaard | Anette Holck Draborg | ... | Gunnar Houen
  • Special Issue
  • - Volume 2015
  • - Article ID 279890
  • - Research Article

Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt

Vasco C. Romão | Maria José Santos | ... | Helena Canhão
  • Special Issue
  • - Volume 2015
  • - Article ID 595273
  • - Research Article

Study of Osteoarthritis Treatment with Anti-Inflammatory Drugs: Cyclooxygenase-2 Inhibitor and Steroids

Hongsik Cho | Andrew Walker | ... | Karen A. Hasty
BioMed Research International
 Journal metrics
Acceptance rate30%
Submission to final decision81 days
Acceptance to publication43 days
CiteScore2.410
Impact Factor2.197
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.